Transoral incisionless fundoplication demonstrates durability at up to 9 years
Goals: To assess the long-term results of transoral incisionless fundoplication (TIF 2). Background: TIF with the EsophyX2 is an accepted procedure to treat gastroesophageal reflux disease (GERD). Long-term data have been limited. We report clinical outcomes of 151 patients followed up to 9 years. S...
Main Authors: | Reginald C. W. Bell, Katherine Freeman, Rachel Heidrick, Shahin Ayazi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-04-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848211004827 |
Similar Items
-
The evolution of TIF: transoral incisionless fundoplication
by: Glenn M. Ihde
Published: (2020-05-01) -
Transoral incisionless fundoplication for Jehovah’s Witnesses: A case report discussing safety and durability
by: Medhat Y Fanous, et al.
Published: (2017-12-01) -
Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years
by: Pier Alberto Testoni, et al.
Published: (2019-05-01) -
Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
by: Deepanshu Jain, et al.
Published: (2016-03-01) -
Transoral Incisionless fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal
by: Amy Tyberg, et al.
Published: (2018-05-01)